- |||||||||| Trial primary completion date: Global (clinicaltrials.gov) - May 19, 2014
P=N/A, N=64, Completed, Recruiting --> Completed Trial primary completion date: Dec 2013 --> Oct 2013
- |||||||||| Trial completion date: Global (clinicaltrials.gov) - May 19, 2014
P=N/A, N=64, Completed, Trial primary completion date: Dec 2013 --> Oct 2013 Trial completion date: Dec 2013 --> Oct 2013
- |||||||||| Trial completion: Global (clinicaltrials.gov) - May 19, 2014
P=N/A, N=64, Completed, Trial completion date: Dec 2013 --> Oct 2013 Active, not recruiting --> Completed
- |||||||||| Trial initiation date: Effects of Bracing on Knee Osteoarthritis (OA) (clinicaltrials.gov) - May 8, 2014
P=N/A, N=25, Completed, Trial primary completion date: Aug 2014 --> May 2014 Initiation date: Apr 2013 --> Jul 2013
- |||||||||| Belbuca (buprenorphine BEMA) / Collegium Pharma
Trial primary completion date: Long-term Open-Label Safety Study to Evaluate EN3409 (clinicaltrials.gov) - May 1, 2014 P3, N=200, Recruiting, Trial completion date: Mar 2014 --> Jul 2014 Trial primary completion date: Jan 2014 --> Jun 2015
- |||||||||| Belbuca (buprenorphine BEMA) / Collegium Pharma
Trial completion date: Long-term Open-Label Safety Study to Evaluate EN3409 (clinicaltrials.gov) - May 1, 2014 P3, N=200, Recruiting, Trial primary completion date: Jan 2014 --> Jun 2015 Trial completion date: Jan 2014 --> Jun 2015
|